Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Circadian Rhythm on the Spread of Circulating Tumor Cells in Lung Cancer Patients

NCT05988970 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT05988970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05988970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Circadian Rhythm on the Spread of Circulating Tumor Cells in Lung Cancer Patients
Lead sponsor
Institut Claudius Regaud
Phase
Not applicable
Overall status
Completed
Start date
January 29, 2024
Completion date
January 21, 2026
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer